Venatorx Pharmaceuticals is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.
View Top Employees from Venatorx Pharmaceuticals, Inc.Website | https://www.venatorx.com/ |
Revenue | $10 million |
Funding | $54.9 million |
Employees | 78 (78 on RocketReach) |
Founded | 2010 |
Address | 74 E Swedesford Road Suite 100, Malvern, Pennsylvania 19355, US |
Phone | (610) 644-8935 |
Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
Category | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Drug Discovery, Healthcare, Science and Engineering, Health Care, Medical, Pharmaceutical |
Web Rank | 11 Million |
Keywords | venatorx, vnrx-5133, venato rx |
Competitors | Cempra Pharmaceuticals, Microcide, Nabriva Therapeutics plc, Sequella, Inc., Tetraphase Pharmaceuticals |
SIC | 28, 283 |
NAICS | 3254, 32541, 325, 32 |
Looking for a particular Venatorx Pharmaceuticals, Inc. employee's phone or email?
The Venatorx Pharmaceuticals, Inc. annual revenue was $10 million in 2023.
Christopher Burns is the President and Chief Executive Officer of Venatorx Pharmaceuticals, Inc..
78 people are employed at Venatorx Pharmaceuticals, Inc..
Venatorx Pharmaceuticals, Inc. is based in Malvern, Pennsylvania.
The NAICS codes for Venatorx Pharmaceuticals, Inc. are [3254, 32541, 325, 32].
The SIC codes for Venatorx Pharmaceuticals, Inc. are [28, 283].